NICE/Helsinki

Descripción

Molecular Theraputics Fichas sobre NICE/Helsinki, creado por lumen7 el 27/04/2013.
lumen7
Fichas por lumen7, actualizado hace más de 1 año
lumen7
Creado por lumen7 hace alrededor de 11 años
43
0

Resumen del Recurso

Pregunta Respuesta
NICE -National Institute for Health and Clinical Excellence- origin NICE's role was set out in the 2004 White Paper ´Choosing health: making healthier choices easier´.
NICE role set out key principles for helping people make healthier and more informed choices about their health. bring together knowledge and guidance on ways of promoting good health and treating ill health in a cost-effective way.
NICE and the NHS NHS required to provide funding and resources for medicines and treatments recommended by NICE enforceable three months from the date of publication
NICE & Medicines and devices does not license. appraises new drugs/devices to make sure effective and cost effective products made available to patients quickly and to minimise variations in the available of treatments.
Mostrar resumen completo Ocultar resumen completo

Similar

recombinant protiens
lumen7
transgenic animals
lumen7
Stem Cells
lumen7
Gene silencing
lumen7
simple protein therapy
lumen7
Theraputic antibodies
lumen7
Section A questions
lumen7
Molecular Theraputics
lumen7
vaccines
lumen7
Cancer Gene therapy
lumen7
Transplantation
lumen7